October 3, 2022
mayank
Nippon India Nifty Pharma ETF
NAV Growth: Rs 13.0939
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Fund Manager:
1) Mehul Dama
Education: Mr. Dama has done C.A. & B.Com
Experience: Prior to joining Nippon India Mutual Fund, he has worked with Goldman Sachs Asset Management(India) Private Ltd. as Vice President, Benchmark Asset Management Company Private Ltd. as Assistant Vice President and Lovelock & Lewes as Assistant Manager.
Investment Details
| Min. Investment (Rs) | 1,000 |
| Min. Addl Investment (Rs) | — |
| Min. SIP Investment (Rs) | — |
| Min. Withdrawal (Rs) | — |
| Min. No of Cheques | — |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 0 |
Basic Details
| Fund House | Nippon India Mutual Fund |
| Launch Date | 02-Jul-21 |
| Return Since Launch | -8.07% |
| Benchmark | NIFTY Pharma TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 91 Cr |
| (As on 31-Aug-2022) | |
| Expense Ratio | 0.19% |
| (As on 31-Aug-2022) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 81.00% |
Nippon India Nifty Pharma ETF Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Nippon Ind Nifty Pharma ETF | -8.2 | 0.76 | 2.14 | 7.1 | -4.1 | -9.74 | — | — | — | — |
| S&P BSE Healthcare TRI | -10.34 | 0.67 | 1.45 | 8.47 | -3.49 | -9.92 | — | — | — | — |
| Equity: Sectoral-Pharma | -9.17 | 0.69 | 1.88 | 8.01 | -3.19 | -9 | — | — | — | — |
| Rank within category | 6 | 6 | 7 | 12 | 12 | 8 | — | — | — | — |
| Number of funds in category | 15 | 16 | 16 | 15 | 15 | 13 | 9 | 4 | 3 | 3 |
Nippon India Nifty Pharma ETF Peer Comparison
| Fund name | Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) |
| Nippon Ind Nifty Pharma ETF | Unrated | -9.74 | — | — | 0.19 | 91 | -8.07 | — | 1yrs 3mo | 81.00 |
| Nippon Ind Pharma Reg | Unrated | -8.27 | 26.20 | 16.96 | 1.96 | 4,588 | 19.98 | 1.00 (30) | 18yrs 4mo | 27.00 |
| ICICI Pru Pharma Hlthcr & Diagn Reg | Unrated | -9.92 | 26.70 | — | 2.12 | 2,465 | 16.65 | 1.00 (15) | 4yrs 2mo | 45.00 |
| Mirae Asset Helthcr Reg | Unrated | -7.63 | 29.45 | — | 2.09 | 1,723 | 20.25 | 1.00 (365) | 4yrs 3mo | 26.00 |
| SBI Helthcr Opp Reg | Unrated | -6.75 | 26.13 | 12.38 | 2.12 | 1,675 | 15.44 | 0.50 (15) | 23yrs 3mo | 27.00 |
Portfolio Analysis
| No. of Stocks | 20 |
| Top 10 Stocks | 82.51% |
| Top 5 Stocks | 64.65% |
| Top 3 Sectors | 99.63% |
| Portfolio P/B Ratio | 4.00 |
| Portfolio P/E Ratio | 37.22 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 67,044 | 55,278 |
| Giant (%) | 22.91 | 19.26 |
| Large (%) | 40.20 | 36.52 |
| Mid (%) | 35.38 | 36.17 |
| Small (%) | 1.51 | 7.94 |
| Tiny (%) | — | 0.55 |
Chanakya’s Mutual Fund Guidance For Nippon India Nifty Pharma ETF
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online: https://mf.nipponindiaim.com/
Stock Research Reports:
https://www.analysislibrary.com/
NFO Guidance:
https://sahifund.com/category/nfos/
Chanakya’s Mutual Fund Guidance on YouTube
https://www.youtube.com/c/ChanakyaNiPothi
Join Chanakya’s Telegram Channel @
https://t.me/chanakyanipothi